Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy
ConclusionThe prevalence of sarcopenia in HNC patients receiving CCRT was 27%. Its presence before treatment was a significant predictor of incomplete CCRT and poor DSS rate in HNC patients.
Source: European Archives of Oto-Rhino-Laryngology - Category: ENT & OMF Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | ENT & OMF | Head and Neck Cancer | HNSCC | Skin Cancer | Squamous Cell Carcinoma | Study